Smouldering multiple myeloma: To seek or not to seek? To treat or not to treat. That is the question-Reference-Cited by-同舟云学术

Smouldering multiple myeloma: To seek or not to seek? To treat or not to treat. That is the question

Published:2024-03 Issue:4 Volume:204 Page:1141-1142
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Vaxman Iuliana¹²³^ORCID,Gatt Moshe E.⁴^ORCID

Affiliation:

1. Institute of Haematology Davidoff Cancer Center, Rabin Medical Center Petah‐Tikvah Israel

2. Sackler Faculty of Medicine Tel‐Aviv University Tel‐Aviv Israel

3. Division of Haematology Mayo Clinic Rochester Minnesota USA

4. Department of Haematology, Hadassah Medical Center, Faculty of Medicine Hebrew University of Jerusalem Jerusalem Israel

Abstract

In this issue, the British Society for Haematology presents guidelines for the diagnosis and management of patients with smouldering multiple myeloma (SMM). The authors provide a practical, evidence‐based approach to managing these patients. Key questions remain yet unsolved.Commentary on: Hughes et al. Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper. Br J Haematol 2024;204:1193‐1206.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.19369

Reference5 articles.

1. Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper

2. Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria

3. Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma

4. Lenalidomide-dexamethasone versus observation in high-risk smoldering myeloma after 12 years of median follow-up time: A randomized, open-label study